119 related articles for article (PubMed ID: 11781825)
1. Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2.
Miethe J; Schwartz C; Wottrich K; Wenning D; Klempnauer KH
Oncogene; 2001 Dec; 20(56):8116-24. PubMed ID: 11781825
[TBL] [Abstract][Full Text] [Related]
2. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
Thiel G; Al Sarraj J; Vinson C; Stefano L; Bach K
J Neurochem; 2005 Jan; 92(2):321-36. PubMed ID: 15663480
[TBL] [Abstract][Full Text] [Related]
3. Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2).
Steinmüller L; Thiel G
Biol Chem; 2003 Apr; 384(4):667-72. PubMed ID: 12751796
[TBL] [Abstract][Full Text] [Related]
4. Identification of human myometrial target genes of the c-Jun NH2-terminal kinase (JNK) pathway: the role of activating transcription factor 2 (ATF2) and a novel spliced isoform ATF2-small.
Bailey J; Europe-Finner GN
J Mol Endocrinol; 2005 Feb; 34(1):19-35. PubMed ID: 15691875
[TBL] [Abstract][Full Text] [Related]
5. v-Myc, but not Max, possesses domains that function in both transcription activation and cellular transformation.
Min S; Taparowsky EJ
Oncogene; 1992 Aug; 7(8):1531-40. PubMed ID: 1630816
[TBL] [Abstract][Full Text] [Related]
6. Regulation of GTP cyclohydrolase I gene transcription by basic region leucine zipper transcription factors.
Al Sarraj J; Vinson C; Han J; Thiel G
J Cell Biochem; 2005 Dec; 96(5):1003-20. PubMed ID: 16149046
[TBL] [Abstract][Full Text] [Related]
7. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
[TBL] [Abstract][Full Text] [Related]
8. Activation of gene transcription by the amino terminus of the N-Myc protein does not require association with the protein encoded by the retinoblastoma suppressor gene RB1.
Cziepluch C; Wenzel A; Schürmann J; Schwab M
Oncogene; 1993 Oct; 8(10):2833-8. PubMed ID: 8378092
[TBL] [Abstract][Full Text] [Related]
9. ATF2 confers radiation resistance to human melanoma cells.
Ronai Z; Yang YM; Fuchs SY; Adler V; Sardana M; Herlyn M
Oncogene; 1998 Jan; 16(4):523-31. PubMed ID: 9484842
[TBL] [Abstract][Full Text] [Related]
10. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
11. Lack of transcriptional repression by max homodimers.
Yin X; Grove L; Prochownik EV
Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
[TBL] [Abstract][Full Text] [Related]
12. Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.
Crouch DH; Fisher F; La Rocca SA; Goding CR; Gillespie DA
Nucleic Acids Res; 2005; 33(16):5235-42. PubMed ID: 16166655
[TBL] [Abstract][Full Text] [Related]
13. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
Kim ES; Sohn YW; Moon A
Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
[TBL] [Abstract][Full Text] [Related]
15. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
18. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38.
Ouwens DM; de Ruiter ND; van der Zon GC; Carter AP; Schouten J; van der Burgt C; Kooistra K; Bos JL; Maassen JA; van Dam H
EMBO J; 2002 Jul; 21(14):3782-93. PubMed ID: 12110590
[TBL] [Abstract][Full Text] [Related]
19. Function of the c-Myc oncogenic transcription factor.
Dang CV; Resar LM; Emison E; Kim S; Li Q; Prescott JE; Wonsey D; Zeller K
Exp Cell Res; 1999 Nov; 253(1):63-77. PubMed ID: 10579912
[TBL] [Abstract][Full Text] [Related]
20. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
